Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
Global & Regional Health Technology Assessment|January 11, 2023
Clinical and economic benefits of a new paradigm of HCV diagnosis and treatmentStefano Fagiuoli, Matteo Ruggeri, Filipa Aragao, et al.Journal of Medical Economics|September 16, 2025
Navigating the economic value of treatment sequencing in large B-cell lymphoma: insights into optimizing value and patient outcomes of CAR T-cell and other available therapies in BrazilSamir Nabhan, Bradley Kievit, Rob Blissett, et al.Pharmacoeconomics|October 8, 2025
Patient-Level Health Economic Modeling in Excel Without VBA: A TutorialRob Blissett, Will Sullivan, Inola Subban, et al.Liver International : Official Journal of the International Association for the Study of the Liver|July 19, 2017
In an era of highly effective treatment, hepatitis C screening of the United States general population should be consideredZobair Younossi, Deidre Blissett, Rob Blissett, et al.Current Medical Research and Opinion|April 17, 2020
Cost-effectiveness of increased screening and treatment of chronic hepatitis C in KoreaDo Young Kim, Gabriel Wong, Janet Lee, et al.Pharmacoeconomics - Open|December 15, 2023
The Efficiency of Increased HCV Testing and Treatment Strategies in Spain to Achieve Elimination GoalsJose Luis Calleja, Jaime Espin, Ankita Kaushik, et al.Antimicrobial Agents and Chemotherapy|August 27, 2025
Cost-effectiveness of olorofim in the treatment of invasive aspergillosis in patients with limited suitable alternative treatment options: a US payer perspectiveThomas J Walsh, Craig I Coleman, Rob Blissett, et al.MDM Policy & Practice|June 27, 2025
A Cost-Effectiveness Analysis of Diffuse Large B-Cell Lymphoma Treatment Pathways in the United StatesAnik R Patel, Bradley Kievit, Ken Hasegawa, et al.Plos One|January 9, 2025
Achieving the state of Georgia 25% HIV incidence reduction target among men who have sex with men in Atlanta through expanded use of multimodal pre-exposure prophylaxis: A mathematical modelJeremy Fraysse, Sarah-Jane Anderson, Justin C Smith, et al.Expert Review of Pharmacoeconomics & Outcomes Research|March 10, 2023
Budget impact analysis of transurethral water vapor therapy for treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia in the Spanish national healthcare systemAlberto De la Cuadra-Grande, Jorge Rioja-Zuazu, Mario Domínguez-Esteban, et al.Pageof 2